The centerpiece of the Kalypsys suite of technologies is a proprietary state-of-the-art, fully automated robotic ultra-high throughput screening and profiling system. This technology enables scientists to interrogate targets in 1536 well-based biochemical and disease-relevant cellular assays. The system can access on-line storage of over 2 million compounds and generate up to 1.5 million data points per day. The technology also supports drug property profiling, including assessment of ADME and safety characteristics.
Kalypsys technologies are available to customers through Kalypsys Systems. On September 8, 2006 Kalypsys announced a broad collaboration with Panasonic Factory Solutions Co. Ltd. for the development and commercialization of next generation drug discovery systems. For more information, visit Kalypsys Systems.